Guggenheim Raises Its Price Target on Arcutis Biotherapeutics, Inc. (ARQT) to $35 and Maintains a Buy Rating

On February 27, 2026, Guggenheim raised its terms people connected Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) to $35 from $34 and maintained a Buy rating. The steadfast said it remains “encouraged” by the trajectory of Zoryve and the company’s efforts to maximize its worth done commercialization.

On February 26, 2026, TD Cowen raised its terms people to $35 from $30 and kept a Buy rating, updating its exemplary pursuing Q4 results arsenic absorption accrued full-year 2026 guidance.

On February 25, 2026, Arcutis Biotherapeutics reported Q4 EPS of 13c, compared to the 9c statement estimate. Q4 gross was $129.5M versus statement of $113.03M. President and Chief Executive Officer Frank Watanabe said that successful 2025 the institution delivered much than 90% year-over-year maturation successful nett merchandise revenue, reflecting request for ZORYVE, execution crossed aggregate merchandise launches leveraging its differentiated profile, and aboriginal penetration into the topical steroid market. Watanabe added that the institution is entering the adjacent signifier of maturation with a coagulated currency presumption and resources to put successful ZORYVE’s continued maturation and pipeline advancement.

Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) is simply a biopharmaceutical institution focused connected processing and commercializing treatments for dermatological diseases.

While we admit the imaginable of ARQT arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 12 Best Tech Stocks that Beat Earnings Estimates and 40 Most Popular Stocks Among Hedge Funds Heading Into 2026

Disclosure: None. Follow Insider Monkey connected Google News.